IndiaRF to acquire API and CRAMS business of Ind-Swift for Rs 1,650 cr
Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Piramal Enterprises
Piramal Pharma lists on BSE and NSE
Piramal Pharma includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organisation (CDMO);…
Piramal Pharma unveils its Sustainability Report FY21–22
The report articulates PPL’s ESG strategic and operational framework, and execution roadmap, including specific objective targets
Piramal Enterprises announces demerger and simplification of corporate structure
The company plans to create two separate listed entities in financial services and pharmaceuticals
Carlyle Group to acquire 20 per cent stake in Piramal Pharma
The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals…
Piramal collaborates with BerGenBio to develop leukemia treatment
The collaboration will be focused on the development of bemcentinib for the treatment of elderly patients with relapsed Acute…
Piramal Enterprises raises capital of Rs 5,400 crores
The company also plans to raise Rs 1,750 crores through the preferential allotment of CCDs to Canadian institutional investor,…
Piramal’s Pharma business grows over 10 per cent in FY19
Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing…
Piramal to expand pharma presence in US, Europe and Japan
Two more products will be introduced
Piramal Enterprises acquires four brands from Pfizer for Rs 110 crore
The agreement also includes the trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka Piramal…